We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 921 results
  1. Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis

    Homeodomain transcription factor A9 (HOXA9) is a member of the HOX cluster family of transcription factors that are crucially involved in embryo...

    U. Sangeetha Shenoy, Dhanraj Salur Basavarajappa, ... Raghu Radhakrishnan in Clinical and Experimental Medicine
    Article Open access 21 June 2024
  2. Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancer

    Purpose

    This study aims to investigate the expression patterns and clinical significance of miR-140-3p and homeobox A9 (HOXA9) in colorectal cancer...

    Wei Cui, Xueliang Bai, ... Yanfeng ** in Journal of Cancer Research and Clinical Oncology
    Article Open access 29 January 2024
  3. Evaluation of the HOXA9 and MEIS1 genes as a potential biomarker in adult acute myeloid leukemia

    Background

    Acute myeloid leukemia (AML) is a heterogeneous disorder encompassing a set of hematopoietic tumors that develop when the myeloid precursor...

    Amira M. N. Abdelrahman, Fetnat Mahmoud Tolba, ... Naglaa M. Hassan in Egyptian Journal of Medical Human Genetics
    Article Open access 23 January 2023
  4. A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML

    Relapse is a major challenge to therapeutic success in acute myeloid leukemia (AML) and can be partly associated with heterogeneous leukemic stem...

    Anna Lieske, Eric Agyeman-Duah, ... Tobias Maetzig in Leukemia
    Article Open access 14 December 2022
  5. MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathway

    Background

    Previous studies had shown that microRNA-638 (miR-638) exhibited different effects in malignant tumors. Moreover, the function of miR-638...

    Qian Xu, Qianqian Zhang, ... Yuan Yu in World Journal of Surgical Oncology
    Article Open access 20 August 2021
  6. Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia

    Chromosome translocations involving the MLL gene are common rearrangements in leukemia. Such translocations fuse the MLL 5’-region to partner genes...

    Kazutsune Yamagata, Mika Shino, ... Issay Kitabayashi in Leukemia
    Article 09 May 2021
  7. PHF6 suppresses self-renewal of leukemic stem cells in AML

    Acute myeloid leukemia is characterized by uncontrolled proliferation of self-renewing myeloid progenitors accompanied by a differentiation arrest....

    Sapana S. Jalnapurkar, Aishwarya S. Pawar, ... Vikram R. Paralkar in Leukemia
    Article Open access 14 July 2024
  8. Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia

    In KMT2A -rearranged acute lymphoblastic leukemia (ALL), an aggressive malignancy, oncogenic KMT2A-fusion proteins inappropriately recruit DOT1L to...

    Pauline Schneider, Nicholas T. Crump, ... Ronald W. Stam in Experimental Hematology & Oncology
    Article Open access 22 September 2023
  9. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells

    MicroRNAs (miRNAs) are commonly deregulated in acute myeloid leukemia (AML), affecting critical genes not only through direct targeting, but also...

    Edith Schneider, Nicole Pochert, ... Arefeh Rouhi in Leukemia
    Article 25 November 2019
  10. Development and validation of a predictive model in diagnosis and prognosis of primary glioblastoma patients based on Homeobox A family

    Background

    Homeobox A (HOXA) family is involved in the development of malignancies as either tumor suppressors or oncogenes. However, their roles in...

    Zong-Qing Zheng, Gui-Qiang Yuan, ... Zhong Wang in Discover Oncology
    Article Open access 23 June 2023
  11. In silico analysis of differentially expressed-aberrantly methylated genes in breast cancer for prognostic and therapeutic targets

    Breast cancer (BC) is the leading cause of death among women across the globe. Abnormal gene expression plays a crucial role in tumour progression,...

    Ashita Gadwal, Purvi Purohit, ... Praveen Sharma in Clinical and Experimental Medicine
    Article 07 April 2023
  12. Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia

    Scribble complex proteins can influence cell fate decisions and self-renewal capacity of hematopoietic cells. While specific cellular functions of...

    Theresa Eifert, Chen-Jen Hsu, ... Florian H. Heidel in Leukemia
    Article Open access 16 August 2023
  13. Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancer

    Background

    Low-dose Computed Tomography (CT) is used for the detection of pulmonary nodules, but the ambiguous risk evaluation causes overdiagnosis....

    Chaoxiang Du, Lijie Tan, ... Jun Yin in Journal of Cancer Research and Clinical Oncology
    Article Open access 05 February 2024
  14. SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

    KMT2A -rearranged (KMT2A-R) is an aggressive and chemo-refractory acute leukemia which mostly affects children. Transcriptomics-based characterization...

    Antonella Di Mambro, Yoana Arroyo-Berdugo, ... Maria Teresa Esposito in Oncogene
    Article Open access 27 October 2023
  15. Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion

    Hiroto Yanagisawa, Shuichi Mizuta, ... Yasufumi Masaki in Annals of Hematology
    Article 08 June 2020
  16. Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia

    Background

    Acute myeloid leukemia (AML) is a common leukemia with low cure rate and poor prognosis among pediatric patients. The regulation of AML...

    Huawei Zhu, Yanbo Xu, ... Yubo Liu in Journal of Cancer Research and Clinical Oncology
    Article 22 August 2023
  17. Panobinostat (LBH589) increase survival in adult xenografic model of acute lymphoblastic leukemia with t(4;11) but promotes antagonistic effects in combination with MTX and 6MP

    Patients diagnosed with acute lymphoblastic leukemia (ALL) bearing t(4;11)/MLL-AF4 have aggressive clinical features, poor prognosis and there is an...

    Daniel Antunes Moreno, Howard Lopes Ribeiro Junior, ... Luiz Gonzaga Tone in Medical Oncology
    Article 29 September 2022
  18. Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis

    Insufficiency of polycomb repressive complex 2 (PRC2), which trimethylates histone H3 at lysine 27, is frequently found in primary myelofibrosis and...

    Daisuke Shinoda, Yaeko Nakajima-Takagi, ... Atsushi Iwama in Leukemia
    Article 08 September 2021
  19. Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells

    Engineered T cells have been shown to be highly effective in cancer immunotherapy, although T cell exhaustion presents a challenge for their...

    Rongqun Guo, Wei Li, ... Yong** Song in Experimental Hematology & Oncology
    Article Open access 14 May 2022
  20. HOXA9 is a novel myopia risk gene

    Purpose

    A recent meta-analysis revealed PAX6 as a risk gene for myopia. There is a link between PAX6 and HOXA9 . Furthermore, HOXA9 has been reported...

    Chung-Ling Liang, Po-Yuan Hsu, ... Suh-Hang H. Juo in BMC Ophthalmology
    Article Open access 23 January 2019
Did you find what you were looking for? Share feedback.